de Witte T - Search Results

1

Continuous intravenous administration of daunorubicin and cytarabine for remission induction of poor risk acute myelogenous leukaemias and myelodysplastic syndromes.

Bär BM, de Witte T, de Pauw BE, Haanen C. Bär BM, et al. Among authors: de witte t, de pauw be. Neth J Med. 1990 Feb;36(1-2):19-24. Neth J Med. 1990. PMID: 2314517

2

Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia.

De Witte T, Muus P, De Pauw B, Haanen C. De Witte T, et al. Among authors: de pauw b. Cancer. 1990 Sep 1;66(5):831-7. doi: 10.1002/1097-0142(19900901)66:5<831::aid-cncr2820660503>3.0.co;2-e. Cancer. 1990. PMID: 2386911

3

Intensive chemotherapy for patients with myelodysplastic syndromes and acute myelogenous leukaemia younger than 65 years.

De Witte T, Muus P, De Pauw B, Haanen C. De Witte T, et al. Among authors: de pauw b. Bone Marrow Transplant. 1989 Dec;4 Suppl 3:33-5. Bone Marrow Transplant. 1989. PMID: 2697396 Clinical Trial.

4

[The success of lymphocyte infusion as treatment of leukemia recurrence following allogeneic bone marrow transplantation depends on low percentage of patient's own lymphocytes].

Schattenberg AV, van de Wiel-van Kemenade E, Bär BM, Geurts van Kessel AH, van der Maazen RW, de Witte TJ. Schattenberg AV, et al. Among authors: de witte tj. Ned Tijdschr Geneeskd. 1996 Oct 19;140(42):2087-91. Ned Tijdschr Geneeskd. 1996. PMID: 8965951 Clinical Trial. Dutch.

5

In vitro growth pattern and differentiation predict for progression of myelodysplastic syndromes to acute nonlymphocytic leukaemia.

Raymakers R, De Witte T, Joziasse J, Van der Lely N, Boezeman J, Haanen C. Raymakers R, et al. Among authors: de witte t. Br J Haematol. 1991 May;78(1):35-41. doi: 10.1111/j.1365-2141.1991.tb04379.x. Br J Haematol. 1991. PMID: 2043479

6

Favourable outcome of patients older than 40 years of age after transplantation with marrow grafts depleted of lymphocytes by counterflow centrifugation.

Bär BM, De Witte T, Schattenberg A, Boezeman J, Hoogenhout J. Bär BM, et al. Among authors: de witte t. Br J Haematol. 1990 Jan;74(1):53-60. doi: 10.1111/j.1365-2141.1990.tb02537.x. Br J Haematol. 1990. PMID: 2310697

7

Anthracyclines added to the conditioning regimen for allogeneic bone marrow transplantation are associated with a slower haematopoietic recovery.

Van der Lely N, De Witte T, Raemaekers J, Schattenberg A, Haanen C. Van der Lely N, et al. Among authors: de witte t. Bone Marrow Transplant. 1989 Mar;4(2):163-6. Bone Marrow Transplant. 1989. PMID: 2650786

8

Diabetes insipidus associated with leukaemia.

Smits P, de Witte T, Haanen C, Fennis J. Smits P, et al. Among authors: de witte t. Neth J Med. 1989 Jun;34(5-6):264-9. Neth J Med. 1989. PMID: 2770937

9

Allogeneic bone marrow transplantation after partial lobectomy for aspergillosis of the lung.

Schattenberg A, De Vries F, De Witte T, Cohen O, Donnelly JP, De Pauw BE. Schattenberg A, et al. Among authors: de vries f, de witte t, de pauw be. Bone Marrow Transplant. 1988 Sep;3(5):509-12. Bone Marrow Transplant. 1988. PMID: 2847845

10

Remission-induction of acute lymphoblastic transformation of chronic myeloid leukaemia, followed by long-term maintenance therapy.

de Witte T, de Pauw B, Haanen C. de Witte T, et al. Among authors: de pauw b. Blut. 1986 Apr;52(4):231-5. doi: 10.1007/BF00321082. Blut. 1986. PMID: 3457609

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

502 results

Search Page

Filters